---
title: PD-L1 as a Urine Biomarker in Renal Cell Carcinoma-A Case Series and Proof-of-Concept
  Study
date: '2024-04-13'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38611655/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240413180704&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: In this proof-of-concept study, we show that PD-L1 can be
  detected in the urine of RCC patients. Urine PD-L1 levels were found to correlate
  with the treatment response in mRCC patients and were significantly elevated in
  treatment-naïve RCC ...'
disable_comments: true
---
CONCLUSION: In this proof-of-concept study, we show that PD-L1 can be detected in the urine of RCC patients. Urine PD-L1 levels were found to correlate with the treatment response in mRCC patients and were significantly elevated in treatment-naïve RCC ...